Isoastragaloside II modulates PPAR-α/FXR signaling and bile acid metabolism to ameliorate cholestatic liver diseases (CLD)

European Journal of Pharmacology 2026

View at publisher

Authors: Lan Luo, Wei Liu, Shenglan Qi, Jiamei Chen, Hua Zhang, 慕永平, Gaofeng Chen, Wei'an Yuan, Ping Liu, Linzhang Zhang

DOI: 10.1016/j.ejphar.2026.178995

Cited by: 1

References: 49

Fields of Study & Subjects

Drug Transport and Resistance Mechanisms Liver Disease Diagnosis and Treatment Peroxisome Proliferator-Activated Receptors

References 49